Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSC | P53634 | 5/20 | 0.33 |
| ▸ | CA1 | P00915 | 3/20 | 0.31 |
| ▸ | CA2 | P00918 | 3/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.31 |
| ▸ | GHSR | Q92847 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 2/20 | 0.30 |
| ▸ | CA9 | Q16790 | 2/20 | 0.30 |
| ▸ | CTSB | P07858 | 1/20 | 0.30 |
| ▸ | CTSH | P09668 | 1/20 | 0.30 |
| ▸ | CTSS | P25774 | 1/20 | 0.30 |
| ▸ | CTSK | P43235 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27380018 | 0.88 | SLC1A1 (0.41) | CTSCSSTR4 | |
| SCHEMBL7411955 | 0.88 | SLC1A1 (0.41) | CTSCSSTR4 | |
| SCHEMBL7414221 | 0.83 | CA2 (0.38) | CTSCCA1CA2CA12SSTR4 | |
| SCHEMBL8696045 | 0.83 | CA2 (0.38) | CTSCCA1CA2CA12SSTR4 | |
| SCHEMBL8159878 | 0.82 | CTSC (0.36) | CTSCCA1CA2CA12SSTR4 | |
| SCHEMBL8691331 | 0.81 | — | — | |
| SCHEMBL8691960 | 0.80 | CTSC (0.33) | CTSCSSTR4GHSR | |
| SCHEMBL7397874 | 0.78 | CTSC (0.32) | CTSCSSTR4GHSRCTSBCTSH | |
| SCHEMBL7356049 | 0.78 | CTSC (0.34) | CTSCSSTR4GHSR | |
| SCHEMBL7349455 | 0.77 | CTSB (0.56) | CTSCCTSBCTSHCTSSCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5776718-A | Reversible protease inhibitors | ARRIS PHARMACEUTICAL CORPORATION (US) | 1998-07-07 | — | — | US | disclosed |
| EP-0817778-A1 | REVERSIBLE PROTEASE INHIBITORS | ARRIS PHARMACEUTICAL CORPORATION (US) | 1998-01-14 | — | — | EP | disclosed |
| WO-1996030353-A1 | REVERSIBLE PROTEASE INHIBITORS | ARRIS PHARMACEUTICAL CORPORATION (US) | 1996-10-03 | — | — | WO | disclosed |